Multimodal artificial intelligence in retinopathy of prematurity: A comprehensive narrative review

Xinyu Zhao1, Zhenquan Wu1, Shirou Wu1

  • 1Shenzhen Eye Hospital, Shenzhen Eye Medical Center, Southern Medical University, Shenzhen, China.

Insights

Artificial intelligence (AI) offers promising solutions for managing retinopathy of prematurity (ROP), a major cause of childhood blindness. This review explores AI applications in ROP diagnosis and treatment, addressing current challenges for wider implementation.

Area of Science:

  • Ophthalmology
  • Medical Imaging
  • Artificial Intelligence

Background:

  • Retinopathy of prematurity (ROP) is a significant cause of preventable childhood blindness globally.
  • Current diagnostic methods for ROP, based on subjective fundus image interpretation, suffer from inter-observer variability and manual limitations.
  • Limited screening resources in certain regions exacerbate the challenge of ROP management.

Purpose of the Study:

  • To comprehensively review contemporary advances in artificial intelligence (AI)-driven management of retinopathy of prematurity (ROP).
  • To synthesize AI technologies utilizing retinal imaging, clinical text, and smartphone images for ROP diagnosis, risk prediction, and treatment suggestions.
  • To illustrate AI applications in intelligent diagnosis and treatment of ROP through multimodal imaging.

Main Methods:

  • Systematic review of recent literature on AI applications in retinopathy of prematurity.
  • Analysis of AI technologies applied to retinal imaging, clinical text data, and smartphone-captured images.
  • Evaluation of AI's role in multimodal imaging for ROP diagnosis and treatment.

Main Results:

  • AI demonstrates substantial potential for intelligent ROP management, transforming diagnosis, risk prediction, and treatment suggestions.
  • AI technologies leverage diverse data sources, including retinal images, clinical text, and smartphone images, for enhanced ROP assessment.
  • Multimodal imaging combined with AI shows promise for intelligent diagnosis and treatment of ROP.

Conclusions:

  • Despite progress, challenges in data heterogeneity, model generalizability, and real-world integration need to be addressed for AI in ROP.
  • Actionable insights are provided to accelerate the development of equitable and clinically deployable AI solutions for ROP.
  • AI holds significant potential to reduce ROP-related vision loss globally, particularly in resource-limited settings.

Related Concept Videos